Advertisement
Screener

PUMA BIOTECHNOLOGY, INC. (PBYI) Graph

PBYI Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $56.50M; Cost of revenue $12.47M; Research and development (m); Selling, general and administrative $17.55M.
  • 2026-03-31: Revenue $44.81M; Cost of revenue $10.42M; Research and development (m); Selling, general and administrative $18.42M.
  • 2025-12-31: Revenue $75.45M*; Cost of revenue $23.13M*; Research and development (m); Selling, general and administrative $18.38M*.
  • 2025-09-30: Revenue $54.48M; Cost of revenue $12.17M; Research and development (m); Selling, general and administrative $16.82M.

Product or service

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

PBYI revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Product$53.56MRoyalty$2.94MRevenue$56.50MCost of revenue$12.48MOperating income$7.58MOther income, net$9.00KSelling, general& administrative$17.55MPre-tax income$8.24MNet income$8.19M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$56.50M$12.47M(m)$17.55M(m)(m)$8.19M
2026-03-31$44.81M$10.42M(m)$18.42M(m)(m)-$3.75M
2025-12-31$75.45M*$23.13M*(m)$18.38M*(m)(m)$13.44M*
2025-09-30$54.48M$12.17M(m)$16.82M(m)(m)$8.84M
2025-06-30$52.44M$12.30M(m)$18.05M(m)(m)$5.86M
2025-03-31$46.01M$10.56M(m)$17.60M(m)(m)$2.97M
2024-09-30$80.54M$29.10M(m)$16.82M(m)$291.00K$20.32M
2024-06-30$47.08M$10.66M(m)$24.97M(m)$378.00K-$4.53M
2024-03-31$43.77M$10.73M(m)$21.75M(m)$220.00K-$4.82M
2023-09-30$56.12M$13.28M(m)$22.80M(m)$213.00K$5.80M
2023-06-30$54.57M$11.86M(m)$24.46M(m)$187.00K$2.13M
2023-03-31$52.77M$13.22M(m)$22.49M(m)$147.00K$1.40M
2022-09-30$57.10M$12.49M(m)$23.96M(m)$67.00K-$360.00K
2022-06-30$59.52M$14.92M$11.97M$20.58M(m)$57.00K$9.37M
2022-03-31$45.74M$10.84M$15.24M$20.40M(m)$37.00K-$3.40M
2021-12-31(m)(m)$14.17M*(m)(m)(m)(m)
2021-09-30$46.24M$10.28M$18.84M$26.08M(m)$37.00K-$44.67M
2021-06-30$53.38M$11.97M$18.64M$39.41M$70.02M$38.00K-$5.11M
2021-03-31$98.17M$29.56M$20.23M$28.24M$78.02M$38.00K$16.53M
2020-12-31$52.56M(m)(m)(m)$63.71M*(m)-$14.99M
2020-09-30$50.75M$9.94M$23.34M$29.60M$62.88M$0.00-$31.46M
2020-06-30$70.58M(m)$24.69M$29.35M$63.45M(m)$3.40M
2020-03-31$51.22M(m)$25.45M$30.94M$65.47M(m)-$16.93M
2019-12-31$62.92M(m)(m)(m)(m)(m)-$11.20M
2019-09-30$56.35M(m)$30.03M$31.40M$70.80M(m)-$16.89M
2019-06-30$53.92M$9.32M$36.85M$33.53M$79.70M(m)-$37.42M
2019-03-31$99.07M$7.99M$35.73M$45.51M$89.22M(m)-$10.09M
2018-12-31$71.08M$10.36M*(m)(m)(m)(m)-$30.69M
2018-09-30$62.63M$9.05M$36.36M$28.50M$73.91M(m)-$14.20M
2018-06-30$50.77M$8.83M$43.24M$40.13M$92.21M(m)-$44.34M
2018-03-31$66.52M$6.38M$46.92M$36.60M$89.91M(m)-$24.34M
2017-12-31$21.61M(m)(m)(m)(m)(m)-$64.08M
2017-09-30$6.08M$1.53M$49.50M$32.49M$83.52M(m)-$77.18M
2017-06-30(m)(m)$53.25M$24.93M$78.18M(m)-$77.83M
2017-03-31(m)(m)$54.80M$18.40M$73.20M(m)-$72.86M
2016-12-31(m)(m)(m)(m)(m)(m)-$72.66M
2016-09-30(m)(m)$51.98M$14.02M$66.00M(m)-$65.78M
2016-06-30(m)(m)$54.22M$12.27M$66.48M(m)-$66.60M
2016-03-31(m)(m)$60.21M(m)$71.25M(m)-$70.97M
2015-12-31(m)(m)(m)(m)(m)(m)-$61.72M
2015-09-30(m)(m)$51.92M(m)$60.73M(m)-$60.42M
2015-06-30(m)(m)$59.38M(m)$64.91M(m)-$64.69M
2015-03-31(m)(m)$44.73M(m)$52.60M(m)-$52.45M
2014-12-31(m)(m)(m)(m)(m)(m)-$47.48M
2014-09-30(m)(m)$32.09M(m)$35.96M(m)-$35.84M
2014-06-30(m)(m)$35.00M(m)$38.91M(m)-$38.84M
2014-03-31(m)(m)$16.29M(m)$19.82M(m)-$19.79M
2013-12-31(m)(m)(m)(m)(m)(m)-$15.95M
2013-09-30(m)(m)$12.07M(m)$14.33M(m)-$14.28M
2013-06-30(m)(m)$10.44M(m)$12.71M(m)-$12.65M
2013-03-31(m)(m)$9.53M(m)$11.81M(m)-$11.78M
2012-12-31(m)(m)(m)(m)(m)(m)-$21.91M
2012-09-30(m)(m)$17.78M(m)$25.87M(m)-$25.86M
2012-06-30(m)(m)$13.01M(m)$14.78M(m)-$14.75M
2012-03-31(m)(m)$10.57M(m)$11.85M(m)-$11.83M
2011-09-30(m)(m)(m)(m)$333.93K(m)-$347.43K
2011-06-30(m)(m)(m)(m)$34.27K(m)-$34.27K
2011-03-31(m)(m)(m)(m)$3.94K(m)-$3.94K
2010-12-31(m)(m)(m)(m)$7.00K(m)-$7.00K
2010-09-30(m)(m)(m)(m)$6.63K(m)-$6.63K
2010-06-30(m)(m)(m)(m)(m)(m)-$2.44K

Revenue and expense 4 month

Period endOperating expensesNet income
2010-12-31$6.93K-$6.93K

Revenue and expense 6 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$101.32M$22.90M(m)$35.97M(m)(m)$4.44M
2025-06-30$98.44M$22.86M(m)$35.65M(m)(m)$8.83M
2024-06-30$90.85M$21.39M(m)$46.72M(m)$598.00K-$9.34M
2023-06-30$107.34M$25.07M(m)$46.95M(m)$334.00K$3.53M
2022-06-30$105.25M$25.76M$27.20M$40.98M(m)$94.00K$5.97M
2021-06-30$151.55M$41.53M$38.87M$67.75M$148.14M$75.00K$11.32M
2020-06-30$121.80M(m)$50.15M$60.28M$128.92M(m)-$13.54M
2019-06-30$152.99M$17.30M$72.58M$79.03M$168.92M(m)-$47.51M
2018-06-30$117.28M$15.21M$90.17M$76.74M$182.12M(m)-$68.68M
2017-06-30(m)(m)$108.05M$43.33M$151.38M(m)-$150.70M
2016-06-30(m)(m)$114.42M$23.30M$137.73M(m)-$137.57M
2015-06-30(m)(m)$104.11M(m)$117.51M(m)-$117.15M
2014-06-30(m)(m)$51.30M(m)$58.72M(m)-$58.64M
2013-06-30(m)(m)$19.97M(m)$24.51M(m)-$24.43M
2012-06-30(m)(m)$23.57M(m)$26.63M(m)-$26.58M
2011-06-30(m)(m)(m)(m)$38.21K(m)-$38.21K
2010-06-30(m)(m)(m)(m)(m)(m)-$7.13K

Revenue and expense 8 month

Period endNet income
2007-12-31-$15.09K

Revenue and expense 9 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-09-30$152.92M$35.03M(m)$52.47M(m)(m)$17.67M
2024-09-30$171.39M$50.48M(m)$63.54M(m)$889.00K$10.97M
2023-09-30$163.46M$38.36M(m)$69.75M(m)$547.00K$9.32M
2022-09-30$162.36M$38.26M(m)$64.94M(m)$161.00K$5.61M
2021-09-30$197.80M$51.81M$57.70M$93.83M(m)$112.00K-$33.35M
2020-09-30$172.55M$28.43M$73.49M$89.88M$191.81M$0.00-$45.00M
2019-09-30$209.34M(m)$102.61M$110.44M$239.72M(m)-$64.40M
2018-09-30$179.91M$24.26M$126.53M$105.24M$256.03M(m)-$82.88M
2017-09-30$6.08M$1.53M$157.56M$75.82M$234.90M(m)-$227.88M
2016-09-30(m)(m)$166.40M$37.33M$203.73M(m)-$203.35M
2015-09-30(m)(m)$156.03M(m)$178.25M(m)-$177.56M
2014-09-30(m)(m)$83.39M(m)$94.68M(m)-$94.48M
2013-09-30(m)(m)$32.04M(m)$38.84M(m)-$38.71M
2012-09-30(m)(m)$41.35M(m)$52.50M(m)-$52.44M
2011-09-30(m)(m)(m)(m)$372.14K(m)-$385.64K
2010-09-30(m)(m)(m)(m)$6.63K(m)-$6.63K

Revenue and expense 12 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-12-31$228.37M$58.16M(m)$70.85M(m)$4.67M$31.11M
2024-12-31$230.47M$64.40M(m)$80.16M(m)-$6.18M$30.28M
2023-12-31$235.64M$62.68M(m)$89.93M(m)$1.08M$21.59M
2022-12-31$228.03M$55.09M(m)$89.98M(m)$455.00K$2.00K
2021-12-31$253.16M$63.70M$71.87M$116.29M(m)$324.00K$29.13M
2020-12-31$225.11M$39.37M$97.65M$118.49M$255.51M$207.00K-$59.99M
2019-12-31$272.26M$36.81M$132.85M$141.64M$311.31M$53.00K-$75.59M
2018-12-31$250.99M$34.62M$164.85M$146.17M$345.65M$17.00K-$113.58M
2017-12-31$27.68M$5.57M$207.81M$106.69M$320.07M$0.00-$291.95M
2016-12-31(m)(m)$222.80M$53.80M$276.60M$0.00-$276.01M
2015-12-31(m)(m)$208.47M$31.81M$240.28M$0.00-$239.28M
2014-12-31(m)(m)$122.92M(m)$142.28M$0.00-$141.97M
2013-12-31(m)(m)$45.05M(m)$54.83M$0.00-$54.66M
2012-12-31(m)(m)$49.64M(m)$74.45M$0.00-$74.35M
2011-12-31(m)(m)$826.00K(m)$10.16M(m)-$10.23M
2011-09-30(m)(m)(m)(m)$379.07K(m)-$392.57K
2010-12-31(m)(m)(m)(m)(m)(m)-$15.98K
2009-12-31(m)(m)(m)(m)(m)(m)-$16.84K
2008-12-31(m)(m)(m)(m)(m)(m)-$14.08K

Similar stocks

Stock NameCountryMarket CapPE Ratio
ARVINAS, INC. (ARVN)United States$0.510B58.38
CAPRICOR THERAPEUTICS, INC. (CAPR)United States$0.499B-10.81
Evolus, Inc. (EOLS)United States$0.519B-13.32
Ovid Therapeutics Inc. (OVID)United States$0.487B-14.41
CRESCENT BIOPHARMA, INC. (CBIO)United States$0.529B-5.20
ASSEMBLY BIOSCIENCES, INC. (ASMB)United States$0.481B-13,053.96
Indaptus Therapeutics, Inc. (INDP)United States$0.537B
MapLight Therapeutics, Inc. (MPLT)United States$0.459B-7.10
Quoin Pharmaceuticals Ltd. (QNRX)$0.443B-17.85
Phathom Pharmaceuticals, Inc. (PHAT)United States$0.572B-8.76